6533b7dbfe1ef96bd1271646
RESEARCH PRODUCT
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
Alimuddin ZumlaAlimuddin ZumlaMarkus MaeurerEsam I. AzharZiad A. MemishDavid S.c. Huisubject
medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralImmunization PassiveCOVID-19General MedicineGlobal HealthArticleCOVID-19 Drug TreatmentBetacoronavirusDrug DiscoveryViral therapyMedicineHumansbusinessIntensive care medicineCoronavirus InfectionsHost (network)PandemicsCOVID-19 Serotherapyyear | journal | country | edition | language |
---|---|---|---|---|
2020-02-01 | The Lancet |